Brown Brothers Harriman & Co’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $845K | Sell |
19,793
-16,158
| -45% | -$877K | ﹤0.01% | 554 |
|
|
2026
Q1 | $2.26M | Buy |
35,951
+18,659
| +108% | +$1.49M | 0.01% | 285 |
|
|
2025
Q4 | $1.65M | Buy |
17,292
+4,374
| +34% | +$429K | 0.01% | 303 |
|
|
2025
Q3 | $1.26M | Buy |
12,918
+8,092
| +168% | +$838K | 0.01% | 312 |
|
|
2025
Q2 | $518K | Buy |
4,826
+2,829
| +142% | +$286K | ﹤0.01% | 451 |
|
|
2025
Q1 | $201K | Sell |
1,997
-70
| -3% | -$7.05K | ﹤0.01% | 557 |
|
|
2024
Q4 | $185K | Buy |
2,067
+1,290
| +166% | +$114K | ﹤0.01% | 587 |
|
|
2024
Q3 | $65.1K | Sell |
777
-63
| -8% | -$4.97K | ﹤0.01% | 767 |
|
|
2024
Q2 | $64.7K | Hold |
840
| – | – | ﹤0.01% | 725 |
|
|
2024
Q1 | $57.5K | Sell |
840
-320
| -28% | -$20.6K | ﹤0.01% | 745 |
|
|
2023
Q4 | $67.1K | Buy |
1,160
+249
| +27% | +$13.3K | ﹤0.01% | 688 |
|
|
2023
Q3 | $48.1K | Sell |
911
-1,000
| -52% | -$52.4K | ﹤0.01% | 718 |
|
|
2023
Q2 | $103K | Sell |
1,911
-1,000
| -34% | -$52.2K | ﹤0.01% | 588 |
|
|
2023
Q1 | $146K | Buy |
2,911
+352
| +14% | +$16.6K | ﹤0.01% | 540 |
|
|
2022
Q4 | $118K | Buy |
2,559
+2,027
| +381% | +$87.8K | ﹤0.01% | 565 |
|
|
2022
Q3 | $21K | Sell |
532
-13,033
| -96% | -$523K | ﹤0.01% | 958 |
|
|
2022
Q2 | $506K | Buy |
13,565
+101
| +0.8% | +$4.11K | ﹤0.01% | 311 |
|
|
2022
Q1 | $596K | Buy |
13,464
+40
| +0.3% | +$1.73K | ﹤0.01% | 318 |
|
|
2021
Q4 | $570K | Buy |
13,424
+652
| +5% | +$27.4K | ﹤0.01% | 319 |
|
|
2021
Q3 | $554K | Buy |
12,772
+12,714
| +21,921% | +$562K | ﹤0.01% | 306 |
|
|
2021
Q2 | $2K | Sell |
58
-8,270
| -99% | -$348K | ﹤0.01% | 1055 |
|
|
2021
Q1 | $322K | Buy |
8,328
+261
| +3% | +$9.88K | ﹤0.01% | 340 |
|
|
2020
Q4 | $290K | Sell |
8,067
-706
| -8% | -$25.4K | ﹤0.01% | 374 |
|
|
2020
Q3 | $335K | Buy |
8,773
+424
| +5% | +$16.3K | ﹤0.01% | 316 |
|
|
2020
Q2 | $293K | Buy |
8,349
+42
| +0.5% | +$1.51K | ﹤0.01% | 329 |
|
|
2020
Q1 | $271K | Buy |
8,307
+49
| +0.6% | +$1.91K | ﹤0.01% | 309 |
|
|
2019
Q4 | $373K | Buy |
8,258
+5,986
| +263% | +$250K | ﹤0.01% | 352 |
|
|
2019
Q3 | $92K | Buy |
2,272
+166
| +8% | +$7.03K | ﹤0.01% | 552 |
|
|
2019
Q2 | $91K | Buy |
+2,106
| New | +$81K | ﹤0.01% | 498 |
|
|
2018
Q1 | – | Sell |
-111
| Closed | -$3K | – | 841 |
|
|
2017
Q4 | $3K | Buy |
+111
| New | +$3.06K | ﹤0.01% | 934 |
|
|
2016
Q2 | – | Sell |
-64,367
| Closed | -$1.21M | – | 833 |
|
|
2016
Q1 | $1.21M | Hold |
64,367
| – | – | 0.01% | 171 |
|
|
2015
Q4 | $1.19M | Sell |
64,367
-183
| -0.3% | -$3.28K | 0.01% | 180 |
|
|
2015
Q3 | $1.06M | Sell |
64,550
-8,607
| -12% | -$147K | 0.01% | 183 |
|
|
2015
Q2 | $1.29M | Sell |
73,157
-350
| -0.5% | -$6.25K | 0.01% | 174 |
|
|
2015
Q1 | $1.3M | Hold |
73,507
| – | – | 0.01% | 177 |
|
|
2014
Q4 | $974K | Hold |
73,507
| – | – | ﹤0.01% | 202 |
|
|
2014
Q3 | $868K | Sell |
73,507
-29,038
| -28% | -$366K | ﹤0.01% | 208 |
|
|
2014
Q2 | $1.31M | Buy |
102,545
+9,150
| +10% | +$119K | 0.01% | 188 |
|
|
2014
Q1 | $1.26M | Sell |
93,395
-127,715
| -58% | -$1.68M | 0.01% | 171 |
|
|
2013
Q4 | $2.66M | Buy |
221,110
+110,555
| +100% | +$1.31M | 0.01% | 172 |
|
|
2013
Q3 | $1.3M | Buy |
110,555
+1,655
| +2% | +$17.9K | 0.01% | 164 |
|
|
2013
Q2 | $1.01M | Buy |
+108,900
| New | +$924K | ﹤0.01% | 215 |
|
Other funds holding BSX
Brown Brothers Harriman & Co's BSX Position: Q2 2026 in Review
Brown Brothers Harriman & Co reduced its Boston Scientific (BSX) stake by 45% in Q2 2026, selling an estimated $877K and leaving 19,793 shares worth $845K. The position accounts for ﹤0.01% of the portfolio, ranked #554.
Brown Brothers Harriman & Co first reported a position in BSX in Q2 2013 and has held it in 42 quarters since. The position peaked at $2.66M in Q4 2013. 1,474 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Brown Brothers Harriman & Co held 19,793 shares of Boston Scientific worth $845K as of Q2 2026.
- Brown Brothers Harriman & Co sold 16,158 Boston Scientific shares in Q2 2026, an estimated $877K.
- Boston Scientific made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #554 holding.
- Brown Brothers Harriman & Co first reported a position in Boston Scientific in Q2 2013 and has held it in 42 quarters since.
- Brown Brothers Harriman & Co's Boston Scientific position peaked at $2.66M in Q4 2013.
- 1,474 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.